Navigation Links
Nexavar in Combination with Chemotherapy Shown to Extend Progression-Free Survival in Patients with Advanced Breast Cancer
Date:7/22/2009

WAYNE, N.J. and EMERYVILLE, Calif., July 22 /PRNewswire-FirstCall/ -- Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that their first cooperative group-sponsored randomized Phase 2 trial in advanced metastatic breast cancer met its primary endpoint of progression-free survival. The study evaluated Nexavar(R) (sorafenib) tablets in combination with the oral chemotherapeutic, capecitabine, in patients with locally advanced or metastatic HER-2 negative breast cancer. Study findings demonstrated that the median progression-free survival was extended in patients treated with Nexavar and capecitabine compared to patients receiving capecitabine and placebo. These results were statistically significant (p = .0006). In this trial, the safety and tolerability of the combination was as expected and did not show any new or unexpected toxicities. A complete data analysis from this study is expected to be presented at an upcoming scientific meeting.

"Based on these encouraging data, Onyx and Bayer are evaluating various strategies for Nexavar in breast cancer. Nexavar is already benefiting patients worldwide with liver cancer and kidney cancer," said Todd Yancey, M.D., vice president of clinical development at Onyx. "Despite significant treatment advances, breast cancer continues to be the leading cause of cancer death in women.(i) We hope to establish Nexavar as an important new treatment option for patients with this devastating disease."

"This outcome represents a positive signal of the potential benefit of this combination for patients with advanced breast cancer and is the first statistical demonstration of efficacy for a multi-tyrosine kinase inhibitor in this disease," said Jose Baselga, M.D., chairman and professor of medicine at Vall d
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.; Bayer HealthCare Pharmaceuticals Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Onyx Pharmaceuticals Announces a Teleconference and Webcast to Provide an Update on Nexavar; Previously Announced Fourth Quarter and Full Year 2007 Financial Results Teleconference Rescheduled
2. New Analyses Confirm Nexavars Efficacy and Safety in Multiple Patient Subsets With Liver Cancer
3. Nexavar Approved in Japan for the Treatment of Advanced Liver Cancer
4. Phase 3 Trial Initiated to Evaluate Combination Therapy of Nexavar(R) and Tarceva(R) in Patients with Liver Cancer
5. Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Non-Small Cell Lung Cancer
6. Promising drug combination may help those with ocular melanoma that has spread
7. Combination therapy reverses effects of portal hypertension in rats
8. Combination vaccines okay for infants, study shows
9. Antidepressants and painkillers - a dangerous combination
10. Intra-arterial combination chemotherapy induces long-term survival for hepatocellular carcinoma
11. U.S. Oncology Initiates Complete Phase Ib Trial of Brostallicin Combination Therapy in Advanced Solid Tumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2015)... , ... August 01, 2015 , ... Have you ever wondered what “Karma” really means? ... hear the word “Karma.” , Vedic tradition, which gave birth to Hinduism, is one ... of the central concepts of this tradition. According to the wisdom of this heritage, Karma ...
(Date:8/1/2015)... and Greenwich, CT (PRWEB) , ... August 01, ... ... a Great Point Partners I, L.P. (“GPP”) portfolio company has acquired Premier Physical ... — incorporating it into its portfolio of state-of-the-art clinics. , “Our acquisition of ...
(Date:8/1/2015)... (PRWEB) , ... August 01, 2015 , ... On March 19, 2015 Phil Valentine – ... trek of the Appalachian Trail by stepping off Springer Mountain and heading north. ... On July 26th Phil reached Connecticut and was greeted by friends and family. He ...
(Date:7/31/2015)... Clara, CA (PRWEB) , ... August 01, 2015 , ... Super Bowl 50 ... The National Football League’s biggest day each year is the Super Bowl. In the two ... that takes place from the host venue. The 2016 Super Bowl game will mark the ...
(Date:7/31/2015)... ... 2015 , ... The 2nd annual Ride to Fight On will start and ... 2015. The Ride to Fight On is a cycling fundraiser that benefits the West ... Clinic and The University of Tennessee Health Science Center. A health and wellness festival ...
Breaking Medicine News(10 mins):Health News:Nithyananda Yoga Foundation to Conduct Global Webinar on Karma at No Charge on August 1st 2Health News:Professional Physical Therapy Now Largest Outpatient Physical Therapy Provider in Northeast With Acquisition of Premier Physical Therapy & Wellness 2Health News:Connecticut Executive Hikes Appalachian Trail to Raise Awareness About Recovery. 2Health News:Cheap 2016 Super Bowl Tickets at Levi's Stadium: Ticket Down Slashes Ticket Prices on Super Bowl 50 Tickets in Santa Clara, CA at Levi's Stadium 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 3
... Amanda Gardner HealthDay Reporter , TUESDAY, March 20 ... or proposals aimed at governing lifestyle choices such as smoking, ... of becoming a "nanny state"? According to a new ... the issue, agreeing that policies that aim to protect public ...
... Women aged 50 and over with breasts that have ... risk of their breast cancer recurring, according to Swedish ... (EBCC-8) in Vienna today (Wednesday). Dr Louise Eriksson ... found that women with denser breasts had nearly double ...
... , TUESDAY, March 20 (HealthDay News) ... from the left and right arms might help predict ... new study suggests. Researchers found that people with ... each arm are at higher risk of cardiovascular death ...
... biologist and prominent advocate of equality for women in ... Kripke Legend Award for Promotion of Women in Cancer ... Texas MD Anderson Cancer Center. Hopkins, a professor ... (MIT), will deliver the Kripke lecture, Engineering Equity for ...
... Louis has received nearly $4.2 million from the Alzheimer,s ... trials to prevent the symptoms of Alzheimer,s disease. ... history of the 32-year-old association. Randall Bateman, MD, ... Dominantly Inherited Alzheimer,s Network (DIAN) Therapeutic Trials Unit (TTU) ...
... , TUESDAY, March 20 (HealthDay News) -- Some people are ... differences in the way alcohol affects their brain, according to ... while 12 people with a history of alcohol-related blackouts and ... task. The volunteers did the memory task with and without ...
Cached Medicine News:Health News:Many Americans Ambivalent Over Laws Aimed at Healthy Living 2Health News:Many Americans Ambivalent Over Laws Aimed at Healthy Living 3Health News:Dense breasts can nearly double the risk of breast cancer recurrence 2Health News:Dense breasts can nearly double the risk of breast cancer recurrence 3Health News:Blood Pressure Variance Between Arms Points to Heart Risk 2Health News:Kripke Legend Award salutes Nancy Hopkins of MIT 2Health News:Kripke Legend Award salutes Nancy Hopkins of MIT 3Health News:$4.2 million grant helps plan, launch first Alzheimer's prevention trials 2Health News:$4.2 million grant helps plan, launch first Alzheimer's prevention trials 3
(Date:7/30/2015)... VANCOUVER , July 30, 2015 /PRNewswire/ ... that it will report its second quarter 2015 financial ... host a conference call and live webcast at 4:30 ... results, clinical development programs and a general corporate update. ... to the Investor Relations page of the OncoGenex website ...
(Date:7/30/2015)... 2015 PTC Therapeutics, Inc. (NASDAQ: PTCT ... results for the second quarter ending June 30, 2015. ... across the organization.  We are excited to be near ... trial ever conducted with topline results expected in the ... Officer, PTC Therapeutics, Inc. "Translarna is now commercially available ...
(Date:7/30/2015)... China , July 30, 2015 Tianyin ... a pharmaceutical company that specializes in the patented biopharmaceutical, ... pharmaceutical ingredients (API), provided updates regarding the notice it ... LLC (the "Exchange") indicating that the Company was below ... forth in Sections 134 and 1101 of the NYSE ...
Breaking Medicine Technology:PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 10TPI Provides Update Regarding Non-Compliance with NYSE MKT Continued Listing Requirements 2
... SAN DIEGO, March 3, 2011 WHO:   , Awarepoint ... Cowen and Company 31st Annual Health Care Conference taking place ... Wednesday, March 9, 2011. Awarepoint is scheduled to present on ... Cowen and Company,s conferences are major industry events attracting ...
... part of its ongoing mission to serve cancer patients, ... launch of its enhanced website that provides cancer patients, ... spanning cancer prevention, education, patient care, advocacy, and financial ... a powerful new cancer resource navigator tool developed to ...
Cached Medicine Technology:Awarepoint Invited to Present at Cowen & Company 31st Annual Health Care Conference 2Awarepoint Invited to Present at Cowen & Company 31st Annual Health Care Conference 3Breakaway From Cancer® Launches Newly-Enhanced Website Offering Comprehensive, Tailored Support for Cancer Patients 2Breakaway From Cancer® Launches Newly-Enhanced Website Offering Comprehensive, Tailored Support for Cancer Patients 3
... blood gas and electrolyte analyser with reusable ... upon our well established and successful Critical ... perform up to 50 tests form a ... , ,The OPTI R uses a combination ...
... Analysis Kit incorporates detection of T-wave alternans ... DMS Holter analysis tools. Premier 12 makes ... less than 10 seconds and provides visualization ... and validation. The TWA algorithm detects two ...
Velcro® Tracheostomy tube holders are available in Adult, pediatric, and infant sizes....
... Your patient will be more comfortable, ... tracheostomy tube stabilization more secure and to ... tying and untying of twill ties, consider ... adult and neonate/infant sizes, the narrow fastener ...
Medicine Products: